Latest General Catalyst Group Management, LLC Stock Portfolio
$183Million | No. of Holdings #12
General Catalyst Group Management, LLC Performance
2026 Q1-19.28%
YTD-19.28%
2025-31.21%
About General Catalyst Group Management, LLC and 13F Hedge Fund Stock Holdings
General Catalyst Group Management, LLC is a hedge fund based in Cambridge, MA. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, General Catalyst Group Management, LLC reported an equity portfolio of $183.6 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of General Catalyst Group Management, LLC are IOT, , . The fund has invested 34.5% of it's portfolio in SAMSARA INC and 18.8% of portfolio in ARRIVENT BIOPHARMA INC. <br><br> General Catalyst Group Management, LLC opened new stock positions in EIKON THERAPEUTICS INC, COUPANG INC (CPNG) and AMAZON COM INC (AMZN).
General Catalyst Group Management, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$183Million
as of May 15, 2026General Catalyst Group Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that General Catalyst Group Management, LLC made a return of -19.28% in the last quarter. In trailing 12 months, it's portfolio return was -36.49%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| eikon therapeutics inc | 3,229,360 |
| ethos technologies inc | 828,579 |
| coupang inc | 692,462 |
| amazon com inc | 537,753 |
| meta platforms inc | 376,462 |
New stocks bought by General Catalyst Group Management, LLC
Additions
No additions were made to existing positions by General Catalyst Group Management, LLC
Reductions
None of the existing positions were reduced by General Catalyst Group Management, LLC
Sold off
None of the stocks were completely sold off by General Catalyst Group Management, LLC
Sector Distribution
General Catalyst Group Management, LLC has about 53.7% of it's holdings in Others sector.
- Others
- Technology
| Sector | % |
|---|---|
| Others | 53.7 |
| Technology | 45.4 |
Market Cap. Distribution
General Catalyst Group Management, LLC has about 34.9% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- LARGE-CAP
- MID-CAP
| Category | % |
|---|---|
| UNALLOCATED | 53.7 |
| LARGE-CAP | 34.9 |
| MID-CAP | 10.9 |
Stocks belong to which Index?
About 0% of the stocks held by General Catalyst Group Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
| Index | % |
|---|---|
| Others | 99.5 |
| Top 5 Winners (%) | % | |
|---|---|---|
arrivent biopharma inc | 14.7 % | |
| Top 5 Winners ($) | $ | |
|---|---|---|
arrivent biopharma inc | 4.4 M | |
| Top 5 Losers (%) | % | |
|---|---|---|
fractyl health inc | -79.2 % | |
figma inc | -43.4 % | |
| GTLB | gitlab inc | -42.3 % |
maze therapeutics inc | -27.9 % | |
maplebear inc | -16.7 % | |
General Catalyst Group Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of General Catalyst Group Management, LLC
General Catalyst Group Management, LLC has 12 stocks in it's portfolio. GTLB proved to be the most loss making stock for the portfolio. was the most profitable stock for General Catalyst Group Management, LLC last quarter.
$183.56MTotal Value
12.00Positions
15 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Amazon Com Inc Amazon Com IncAMZN General Catalyst Group Management, LLC's holding in Amazon Com Inc over time | 0.29% | 2,582 | $537.8K 0.29% | Newnew position | |
 Coupang Inc Coupang IncCPNG General Catalyst Group Management, LLC's holding in Coupang Inc over time | 0.38% | 36,677 | $692.5K 0.38% | Newnew position | |
 Gitlab Inc Gitlab IncGTLB General Catalyst Group Management, LLC's holding in Gitlab Inc over time | 10.86% | 921,405 | $19.94M 10.86% | 0%unchanged 0 percentunchanged | |
 Samsara Inc Samsara IncIOT General Catalyst Group Management, LLC's holding in Samsara Inc over time | 34.53% | 2,000,000 | $63.38M 34.53% | 0%unchanged 0 percentunchanged | |
 Meta Platforms Inc General Catalyst Group Management, LLC's holding in Meta Platforms Inc over time | 0.2% | 658 | $376.5K 0.2% | Newnew position | |
Com Arrivent Biopharma IncArrivent Biopharma Inc | 18.79% | 1,494,790 | $34.48M 18.79% | 0%unchanged 0 percentunchanged | |
Com Maze Therapeutics IncMaze Therapeutics Inc | 16.84% | 1,035,910 | $30.92M 16.84% | 0%unchanged 0 percentunchanged | |
Com Maplebear IncMaplebear Inc | 14.5% | 710,711 | $26.62M 14.5% | 0%unchanged 0 percentunchanged | |
Com Eikon Therapeutics IncEikon Therapeutics Inc | 1.76% | 305,233 | $3.23M 1.76% | Newnew position | |
Com Fractyl Health IncFractyl Health Inc | 1.22% | 4,884,190 | $2.24M 1.22% | 0%unchanged 0 percentunchanged | |
Cl A Ethos Technologies IncEthos Technologies Inc | 0.45% | 74,179 | $828.6K 0.45% | Newnew position | |
Class A Com Stk Figma IncFigma Inc | 0.17% | 14,845 | $313.8K 0.17% | 0%unchanged 0 percentunchanged | |